4,722.00
+26.24
+(0.56%)
At close: January 20 at 2:45:02 PM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 46 | 35 | 62 | 63 |
| Avg. Estimate | 187.28B | 158.59B | 637.83B | 706.79B |
| Low Estimate | 185B | 154.51B | 635.17B | 688.34B |
| High Estimate | 188.81B | 161.81B | 643.86B | 720.76B |
| Year Ago Sales | 169.96B | 143.31B | 574.78B | 637.83B |
| Sales Growth (year/est) | 10.19% | 10.66% | 10.97% | 10.81% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AMZN.MX | -- | -- | -- | -- |
| S&P 500 | 9.34% | 11.25% | 14.04% | 13.55% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 1/14/2025 |
| Maintains | HSBC: Buy to Buy | 1/13/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 1/13/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 1/10/2025 |
| Maintains | Wedbush: Outperform to Outperform | 1/6/2025 |
| Maintains | Wolfe Research: Outperform to Outperform | 1/3/2025 |